HLA-DRB1*1301 and *1302 protect against chronic hepatitis B

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 503-507

  Höhler, Thomas ^a   Gerken, Guido ^a   Notghi, Arman ^a   Lubjuhn, Roswitha ^a   Taheri, Homa ^a   Protzer, Ulrike ^a   Löhr, Hans F ^a   Schneider, Peter M ^a   Meyer Zum Büschenfelde, Karl H ^a   Rittner, Christian ^a  

^a NONE

Author keywords

chronic hepatitis B; DRB1* alleles; major histocompatibility complex; protection

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA-DRB1 ANTIGEN; IMMUNOGLOBULIN G; VIRUS DNA;

ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; GENOTYPE; HEPATITIS B; HISTOCOMPATIBILITY COMPLEX; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ADULT; ALLELE; CHRONIC DISEASE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; PROSPECTIVE STUDY; REMISSION; SEROLOGY;

ADULT; ALLELES; CHRONIC DISEASE; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; REMISSION, SPONTANEOUS; SEROLOGIC TESTS;

EID: 0030615169     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80414-X     Document Type: Article

References (29)

1. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet. 342:1993;1335-1339.
2. Wright TL, Lau JYN. Clinical aspects of hepatitis B infection. Lancet. 342:1993;1340-1344.
3. Heathcote EJL, Wong DKH. Pathogenesis and efficacy of modulation of host response in hepatitis B and C. Curr Opin Infect Dis. 7:1994;333-340.
4. Lok ASF, Liang RHS, Chung H-T. Recovery from chronic hepatitis B. Ann Intern Med. 116:1992;957.
5. Shouval D, Adler R, Ilan Y. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors. Hepatology. 17:1993;955-959.
6. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM. Common West African HLA antigens are associated with protection from severe malaria. Nature. 352:1991;595-600.
7. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet. 6:1994;157-162.
8. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet. 344:1994;1194-1195.
9. Forzani B, Actis GC, Verme G, Amoroso A, Borelli I, Curtoni ES, Rumi MG, Picciotto A, Marinucci G, Freni MA. HLA-DR antigens in HBsAg-positive chronic active liver disease with and without associated delta infection. Hepatology. 6:1984;1107-1110.
10. Van Hattum VJ, Schreuder GM, Schalm SW. HLA antigens in patients with various courses after hepatitis B infection. Hepatology. 7:1987;11-14.
11. Yang PM, Sung JL, Chen DS. HLA-A, B, C and DR antigens in chronic hepatitis B viral infection. Hepatogastroentrology. 36:1989;363-366.
12. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of the hepatitis B virus in Gambia. N Engl J Med. 332:1995;1065-1069.
13. Gerken G, Paterlini P, Manns M, Housset C, Terre S, Dienes HP, Hess G, Gerlich WH, Berthelot P, Meyer zum Büschenfelde K-H, Bréchot C. Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S- and S-encoded viral surface antigens. Hepatology. 13:1991;158-166.
14. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol. 69:1978;103-120.
15. Bein G, Gläser R, Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens. 39:1992;68-73.
16. Kimura A, Sasazuki T, Sasazuki K. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. Tsuji K, Aizawa M. HLA 1991. 1992;397-419 Oxford University Press.
17. Svejgaard A. HLA and disease. Rose NR, Friedman H, Fahey JL. 3rd Edn. Manual of Clinical Laboratory Immunology. 1986;American Society of Microbiology, Washington.
18. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 48:1992;361-372.
19. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, Erlich HA, Klitz W. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol. 148:1992;249-258.
20. Emery P, Mach B, Reith W. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in the promoter sequence. Hum Immunol. 38:1993;137-147.
21. Winchester R, Chen Y, Rose S, Selby J, Borkowsky W. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci USA. 92:1995;12374-12378.
22. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations wtih cervical carcinoma show papillomavirus-type specificity. Nature Genet. 6:1994;157-162.
23. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM. Common West African HLA antigens are associated with protection from severe malaria. Nature. 352:1991;595-600.
24. Salazar M, Deulofeut H, Granja C, Deulofeut R, Yunis DE, Marcus-Bagley D, Awdeh Z, Alper CA. Normal HBsAg presentation and T-cell defect in the immune response of non-responders. Immunogenetics. 46:1995;366-374.
25. Rammensee HG, Friede T, Stevanovic. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:1995;178-225.
26. Davenport MP, Ho Shon IAP, Hill AVS. An empirical method for the prediction of T-cell epitopes. Immunogenetics. 42:1995;392-397.
27. Davenport MP, Quinn CL, Chicz RM, Green BM, Willis AC, Lane WS, Bell JI, Hill AVS. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRb chain. Proc Natl Acad Sci USA. 92:1995;6567-6571.
28. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, Frosner G, Will H, Pape GR. Activation of heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol. 69:1995;3358-3368.
29. Löhr HF, Weber W, Schlaak J, Goergen B, Meyer zum Büschenfelde KH, Gerken G. Proliferative response of CD4+ T cell and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology. 22:1995;61-68.